Shenzhen Chipscreen Biosciences CoSHSE:688321 +9.31%73 Operating Margin % is 16.39% as of Mar. 2026, which is 223% above its 10-year median of 5.07. GuruFocus rates SHSE:688321 with a GF Score™ of 73/100 and a GF Value™ of ¥37.53 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 952 Drug Manufacturers companies, Shenzhen Chipscreen Biosciences Co ranks better than 70.69% on this metric.
The historical rank and industry rank for Shenzhen Chipscreen Biosciences Co's Operating Margin % or its related term are showing as below:
SHSE:688321'
s Operating Margin % Range Over the Past 10 Years
Min: -31.43 Med: 5.07 Max: 24.65
Current: 14.94
SHSE:688321's Operating Margin % is ranked better than 70.69% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.58
vs SHSE:688321: 14.94
Shenzhen Chipscreen Biosciences Co Ltd had lost money in 67% of the time over the past 12quarters.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Shenzhen Chipscreen Biosciences Co Operating Margin % Related Terms
Shenzhen Chipscreen Biosciences Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co Operating Margin % Chart
SHSE:688321 vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Chipscreen Biosciences Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Chipscreen Biosciences Co Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shenzhen Chipscreen Biosciences Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen Chipscreen Biosciences Co's Operating Margin % falls into.
Shenzhen Chipscreen Biosciences Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Chipscreen Biosciences Co (SHSE:688321) has a Operating Margin % of 16.39% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. This is 223% above median its historical median of 5.07. According to the industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #279 out of 952 companies in the Drug Manufacturers industry, placing it in the top 29.3%.
Is Shenzhen Chipscreen Biosciences Co's Operating Margin % too high?
Shenzhen Chipscreen Biosciences Co's current Operating Margin % of 16.39% is 223% above median its 10-year median of 5.07. The Drug Manufacturers industry median Operating Margin % is 7.58. Shenzhen Chipscreen Biosciences Co's value of 16.39% is 116.2% above this industry median. Based on the distribution chart, Shenzhen Chipscreen Biosciences Co ranks #279 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shenzhen Chipscreen Biosciences Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Chipscreen Biosciences Co's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shenzhen Chipscreen Biosciences Co ranks #279 out of 952 companies for Operating Margin %. This puts Shenzhen Chipscreen Biosciences Co in the upper half of its industry. The industry median Operating Margin % is 7.58. Shenzhen Chipscreen Biosciences Co's value of 16.39% is 116.2% above this benchmark. While the company's 10-year median is 5.07 vs. the industry median of 7.58, Shenzhen Chipscreen Biosciences Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Chipscreen Biosciences Co's current Operating Margin % of 16.39% is 116.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shenzhen Chipscreen Biosciences Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Chipscreen Biosciences Co's current Operating Margin % is 16.39%, which is 223% above median its own 10-year median of 5.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Chipscreen Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co (SHSE:688321) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥37.53, compared to a current price of ¥26.18 — trading 30.2% below its estimated fair value. The current Operating Margin % is 16.39%, which is 223% above median its 10-year median of 5.07 and 116.2% above the Drug Manufacturers industry median of 7.58. Shenzhen Chipscreen Biosciences Co's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shenzhen Chipscreen Biosciences Co (SHSE:688321), the current Operating Margin % is 16.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Chipscreen Biosciences Co (SHSE:688321) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Chipscreen Biosciences Co stock appears to be undervalued.
The current stock price of ¥26.18 is trading 30.2% below its estimated GF Value™ of ¥37.53.
GuruFocus considers Shenzhen Chipscreen Biosciences Co to be Significantly Undervalued.
Key valuation signals for SHSE:688321:
Operating Margin %: 16.39% (223% above median its 10-year median of 5.07)
GF Value™: ¥37.53 vs. price of ¥26.18 (30.2% below fair value)
Industry Position: 116.2% above the Drug Manufacturers median (#279 of 952)
No single metric tells the full story. See the SHSE:688321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Chipscreen Biosciences Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688321 has been successfully added to your 
